The hepatitis B virus X gene induces p53-mediated programmed cell death.

The human hepatitis B virus (HBV) protein pX is a multifunctional regulatory protein that is known to affect both transcription and cell growth. Here we describe induction of apoptosis in NIH 3T3 polyclonal cell lines upon stimulation of pX expression from a dexamethasone inducible mouse mammary tumor virus (MMTV)-X expression vector. The effect of long-term pX expression on the cell survival of mouse fibroblasts was confirmed in colony generation assays. This effect is not shared either by the other HBV products and it is c-myc mediated, as shown by the use of a dominant negative deletion mutant of c-myc. pX also sensitize cells to programmed cell death after exposure to DNA damaging agents. Taking advantage of stable transfectants carrying the p53val135 temperature-sensitive allele, we directly demonstrate that induction of apoptosis by pX requires p53. In p53 null mouse embryo fibroblasts pX activates transcription and confers an evident growth advantage without loss of cell viability. Although pX protein was not detectable in the experimental conditions we used, our results indicate that its expression affects both cell growth and cell death control.

[1]  G. Natoli,et al.  MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes , 1997, Oncogene.

[2]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[3]  K. Vousden,et al.  p53 in signaling checkpoint arrest or apoptosis. , 1996, Current opinion in genetics & development.

[4]  G. Blandino,et al.  Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes , 1996, Molecular and cellular biology.

[5]  C. Harris,et al.  Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. , 1995, Cancer research.

[6]  R. Lucito,et al.  The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. , 1995, The EMBO journal.

[7]  G. Natoli,et al.  Resistance to Fas-mediated apoptosis in human hepatoma cells. , 1995, Oncogene.

[8]  E. Shaulian,et al.  Induction of apoptosis in HeLa cells by trans-activation-deficient p53. , 1995, Genes & development.

[9]  O. Andrisani,et al.  The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Greenblatt,et al.  Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation , 1995, Journal of virology.

[11]  M. Kastan,et al.  Growth factor modulation of p53-mediated growth arrest versus apoptosis. , 1995, Genes & development.

[12]  S. Elledge,et al.  Hepatitis B virus X protein interacts with a probable cellular DNA repair protein , 1995, Journal of virology.

[13]  J. Cheong,et al.  Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. , 1995, The EMBO journal.

[14]  H. Hermeking,et al.  Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Schneider,et al.  Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Natoli,et al.  Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. , 1994, Oncogene.

[17]  H. Hermeking,et al.  Mediation of c-Myc-induced apoptosis by p53. , 1994, Science.

[18]  A. Sette,et al.  Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope , 1994, The Journal of experimental medicine.

[19]  E. White p53, guardian of Rb , 1994, Nature.

[20]  M. Karin,et al.  p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.

[21]  E. May,et al.  Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. , 1994, Cell death and differentiation.

[22]  K. Koike,et al.  Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. , 1994, The Journal of clinical investigation.

[23]  H. Pan,et al.  Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.

[24]  C. Harris,et al.  Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Zoulim,et al.  Woodchuck hepatitis virus X protein is required for viral infection in vivo , 1994, Journal of virology.

[26]  K. Koike,et al.  Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. , 1994, Oncogene.

[27]  G. Natoli,et al.  Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX , 1994, Molecular and cellular biology.

[28]  G. Natoli,et al.  Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. , 1993, Virology.

[29]  D. Housman,et al.  p53-dependent apoptosis modulates the cytotoxicity of anticancer agents , 1993, Cell.

[30]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[31]  W. Rutter,et al.  Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Natoli,et al.  The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements. , 1993, Oncogene.

[33]  E. White,et al.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.

[34]  R. Anderson,et al.  The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks , 1993, Journal of virology.

[35]  P. Hofschneider,et al.  Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway , 1993, Nature.

[36]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[37]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[38]  G. Natoli,et al.  Characterization of the hepatitis B virus preS/S region encoded transcriptional transactivator. , 1992, Virology.

[39]  Jean‐Pierre Martin,et al.  Altered pathogenicity in the liver induced by a mouse hepatitis virus type 3 thermosensitive mutant , 1991, Journal of Hepatology.

[40]  M. Perricaudet,et al.  Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. , 1991, Biochemical and biophysical research communications.

[41]  A. Siddiqui,et al.  HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions , 1991, Science.

[42]  M. Höhne,et al.  Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. , 1990, The EMBO journal.

[43]  P. Hofschneider,et al.  The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator , 1990, Nature.

[44]  M. Perricaudet,et al.  Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. , 1989, Virology.

[45]  D. Shalloway,et al.  Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF , 1987, Nature.

[46]  J. Yates,et al.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus , 1985, Molecular and cellular biology.

[47]  T. Yen Hepadnaviral X Protein:Review of Recent Progress. , 1996, Journal of biomedical science.

[48]  M. Lai,et al.  Activation of protooncogene c-jun by the X protein of hepatitis B virus. , 1993, Virology.